Historical Valuation
Aethlon Medical Inc (AEMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.21. The fair price of Aethlon Medical Inc (AEMD) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：2.52
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Aethlon Medical Inc (AEMD) has a current Price-to-Book (P/B) ratio of 0.37. Compared to its 3-year average P/B ratio of 0.74 , the current P/B ratio is approximately -49.73% higher. Relative to its 5-year average P/B ratio of 1.17, the current P/B ratio is about -68.01% higher. Aethlon Medical Inc (AEMD) has a Forward Free Cash Flow (FCF) yield of approximately -328.71%. Compared to its 3-year average FCF yield of -184.47%, the current FCF yield is approximately 78.19% lower. Relative to its 5-year average FCF yield of -128.59% , the current FCF yield is about 155.62% lower.
P/B
Median3y
0.74
Median5y
1.17
FCF Yield
Median3y
-184.47
Median5y
-128.59
Competitors Valuation Multiple
AI Analysis for AEMD
The average P/S ratio for AEMD competitors is 0.30, providing a benchmark for relative valuation. Aethlon Medical Inc Corp (AEMD.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for AEMD
1Y
3Y
5Y
Market capitalization of AEMD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of AEMD in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is AEMD currently overvalued or undervalued?
Aethlon Medical Inc (AEMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.21. The fair price of Aethlon Medical Inc (AEMD) is between NaN to NaN according to relative valuation methord.
What is Aethlon Medical Inc (AEMD) fair value?
AEMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Aethlon Medical Inc (AEMD) is between NaN to NaN according to relative valuation methord.
How does AEMD's valuation metrics compare to the industry average?
The average P/S ratio for AEMD's competitors is 0.30, providing a benchmark for relative valuation. Aethlon Medical Inc Corp (AEMD) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Aethlon Medical Inc (AEMD) as of Jan 09 2026?
As of Jan 09 2026, Aethlon Medical Inc (AEMD) has a P/B ratio of 0.37. This indicates that the market values AEMD at 0.37 times its book value.
What is the current FCF Yield for Aethlon Medical Inc (AEMD) as of Jan 09 2026?
As of Jan 09 2026, Aethlon Medical Inc (AEMD) has a FCF Yield of -328.71%. This means that for every dollar of Aethlon Medical Inc’s market capitalization, the company generates -328.71 cents in free cash flow.
What is the current Forward P/E ratio for Aethlon Medical Inc (AEMD) as of Jan 09 2026?
As of Jan 09 2026, Aethlon Medical Inc (AEMD) has a Forward P/E ratio of -0.39. This means the market is willing to pay $-0.39 for every dollar of Aethlon Medical Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Aethlon Medical Inc (AEMD) as of Jan 09 2026?
As of Jan 09 2026, Aethlon Medical Inc (AEMD) has a Forward P/S ratio of 0.00. This means the market is valuing AEMD at $0.00 for every dollar of expected revenue over the next 12 months.